CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced the appointment of Dr. Hongjiang Miao as Chief...
Hence then, the article about nona biosciences appoints dr hongjiang miao as chief ai officer to advance a strategy and ai driven drug discovery was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Nona Biosciences Appoints Dr. Hongjiang Miao as Chief AI Officer to Advance A³ Strategy and AI-Driven Drug Discovery )
Also on site :
- Walmart’s Wicker Rolling Cart With Pretty Pottery Barn Vibes Is 'Perfect for Maximizing Storage in Small Spaces'
- This Weighted Derpy Pillow Mimics a Hug From the ‘KPop Demon Hunters’ Tiger to Help You Gently Fall Asleep
- 1977 'White-Hot' Fleetwood Mac Smash, Called the 'Most Iconic Breakup Album of All Time,' Is Finally Giving Up Its Secrets